The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Pulmonary pathology of severe acute respiratory syndrome in Toronto
Open accessAbstract
The severe acute respiratory syndrome (SARS) pandemic in Toronto resulted in a large number of autopsies on its victims. We describe the pulmonary pathology of patients who died in the 2003 Toronto outbreak. Autopsy material from the lungs of 20 patients who died between March and July 2003 were characterized by histology, molecular biology, and immunohistochemistry for cytokeratins, thyroid transcription factor-1, CD68, Epstein-Barr virus, cytomegalovirus, and human herpes simplex viruses. Matched controls were obtained from patients who died of other causes over the same interval. The mean duration of illness was 27 days (range 5-108 days). Post-mortem lung tissues from 19 of 20 patients with probable SARS were positive for SARS-associated coronavirus by RT-PCR. Histologically, all patients showed varying degrees of exudative and proliferative phase acute lung injury, evidenced in conventional and immunohistochemical stains by edema, inflammatory infiltrate, pneumocyte hyperplasia, fibrinous exudates, and organization. Eight of 20 patients showed predominantly a diffuse alveolar damage pattern of acute lung injury, six showed predominantly an acute fibrinous and organizing pneumonia pattern, and the remainder showed an admixture of the two patterns. Squamous metaplasia and scattered multinucleate giant cells were present in most cases. Vascular fibrin thrombi were a common finding and were often associated with pulmonary infarcts. Special stains demonstrated vascular endothelial damage of both small- and mid-sized pulmonary vessels. Two cases were complicated by invasive fungal disease consistent with Aspergillosis, and another by coinfection with cytomegalovirus. Our findings indicate that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury. Cases of SARS may be complicated by coexistent infections and therapy-related lung injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings are similar to studies reporting the bacteria implicated in secondary infections in patients with MERS-CoV and SARS-CoV.8 , 46 , 47”
From Co-infections in people with COVID-19: a systematic review and meta-analysis. (2020) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,405
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D. E., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,133
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A. M., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D. A. J., Laman, J. D., de Jong, T., van Doornum, G., Lim, W. W. L., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,015
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H.-X., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
Flagged first, then by citations
1 of the 22 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–331 of 331
Otitis with Aspergillus niger in a patient with SARS-CoV-2 and multiple comorbidities
Stoenescu, A. F., VANCEA, G., Ispas, D., Voicu-Pârvu, N., Tudor, N., Precup, G., Scurtu, G., Pişcu, S. A., Popică, A., Bontea, R., et al. (2021) · Romanian Journal of Infectious Diseases · doi:10.37897/rjid.2021.3.2
Pneumonia, Severe Acute Respiratory Syndrome
Fraire, A. E. (2018) · Encyclopedia of pathology · doi:10.1007/978-3-319-69263-0_334
Dangas, G., White, C. J., Kipshidze, N. K. N., Fareed, J., Iversen, P. L., Colombo, A. C. A., & Kipshidze, N. N. (2021) · EMJ Innovation · doi:10.33590/emjinnov/20-00114
(2020) · JACC Basic to Translational Science · doi:10.1016/s2452-302x(20)30205-9
Fungal Infections Complicating COVID-19
Hoenigl, M., & Talento, A. F. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0555-8
Kory, P. D., & Kanne, J. P. (2020) · doi:10.2196/preprints.20614
Berenji, M. (2016) · doi:10.1002/9781119276531.ch21
Reymundo, P. S. L., Santos, A. Y. R., Chavarría, A. P., Álvarez, A. A., Sánchez, J. S. A., & Gutiérrez, R. C. (2022) · Medicina Crítica · doi:10.35366/104868
Covid-19 and low molecular weight heparin therapy: retrospective study of 257 patients.Preprint
Stabile, M., Aschieri, D., Maestri, C., Rosato, L., Novara, P. V., Lanati, G., Dio, M. D., Franco, C., Bisceglie, G., Leddi, G., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-57730/v1
Roden, A. C., Leslie, K. O., Elicker, B. M., & Colby, T. V. (2015) · Cambridge University Press eBooks · doi:10.1017/9781139137201.018 · Cited by 2
Cell Regeneration in Lung Injury
Bromberg, Z., Deutschman, C. S., & Weiss, Y. (2007) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-540-49433-1_28
A Case of Abscessed Pneumonia Due to COVID-19 Infection
Vorobeva, O. V. (2022) · Medicina · doi:10.29234/2308-9113-2022-10-1-32-40
Postmortem Lung Biopsy in a Sample of COVID-19 Patients in Iraq
Al-Zaidi, H. M. H., Abdulrazaq, A. A., Badr, H. M., & Ahmed, B. S. (2022) · SAR Journal of Medicine · doi:10.36346/sarjm.2022.v03i05.003
Mittal, R., Chahal, H. S., & Sandhu, G. S. (2022) · Advances in Infectious Diseases · doi:10.4236/aid.2022.124058
Smith, M. L., Larsen, B. T., & Leslie, K. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79547-0.00016-3
Shulgau, Z., Kamyshanskiy, Y., & Gulyayev, A. Y. (2023) · Eurasian journal of applied biotechnology · doi:10.11134/btp.1.2023.1
Filho, É. C. C., Moreira, M. T., & Castro, F. F. D. S. (2023) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2021.8982
SARS-COV-2: THE 2019 NOVEL CORONAVIRUS
Gahlot, A., & ., R. (2023) · International Journal of Engineering Applied Sciences and Technology · doi:10.33564/ijeast.2023.v08i02.051
SARS-COV-2: THE SECONDARY EXTREMITY SUMMIT OF WHO
HMRITM, & Gahlot, A. (2023) · International Journal of Engineering Applied Sciences and Technology · doi:10.33564/ijeast.2023.v08i02.050
A review on severe acute respiratory syndrome (SARS)
Munna, S., Chiramana, R. B., & Chandra, Y. P. (2023) · Future Journal of Pharmaceuticals and Health Sciences · doi:10.26452/fjphs.v3i4.531
Histopathological changes in lungs of patients with fatal COVID 19 infection: A series of 15 cases
Medhi, P. S., Dowerah, S., Barman, N., & Singh, M. (2022) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_866_21
Post-COVID Mucormycosis-Conceptual Etiology and New Treatment Options
Bavishi, M., Thomas, S., Nair, P., Bavishi, P., & Masariya, B. D. (2024) · Journal of Maxillofacial and Oral Surgery · doi:10.1007/s12663-024-02124-5
De-chun, L., & Yunxia, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-32930-2.00011-8
Pathology of Pulmonary Aspergillosis
Konopka, K. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-76524-7_3
Iqbal, M. Z., Majeed, M. B. B., Saeed, M., Safdar, M., Rahim, K., Hussain, F., Majeed, H., & Younas, U. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274943124010003
Hamdy, M. S. E.-D., Makhlouf, M. M., Ibrahim, M., Hegazy, M. T., Sissy, M. H. E., Soliman, L., El‐Kamah, G. Y., Mahdy, S. M., Farawela, H. M., Matter, M., et al. (2025) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03631-0
Wichmann, D., Hoenigl, M., Koehler, P. A., Koenig, C., Lund, F., Mang, S., Strauß, R., Weigand, M. A., Hohmann, C., Kurzai, O., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01265-w
Remmelink, M., Mendonça, R. D., D’Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trépant, A.-L., Maris, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12799497
Remmelink, M., Mendonça, R. D., D’Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trépant, A.-L., Maris, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12799494
Remmelink, M., Mendonça, R. D., D’Haene, N., Clercq, S. D., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trépant, A.-L., Maris, C., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12799491
Pandey, M. K., May, A., Tan, L., Hughes, H., Jones, J. P., Harrison, W., Bradburn, S., Tyrrel, S., Muthuswamy, B., Berry, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19976885
Metadata
- Authors
- Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J.
- Affiliations
- University Health Network (CA)
- Mount Sinai Hospital (CA)
- Corresponding author
- Butany, Jagdish
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 18
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0893-3952 (ISSN-L)
- PMC
- PMC7100506
- OpenAlex
- W2017745096
- Cited by
- 332
- References
- 22
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 11 · 2023: 14 · 2022: 26 · 2021: 68 · 2020: 112 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 8 · 2012: 5
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Modern Pathology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University Health Network
- University of Toronto
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- SARS, SARS-associated coronavirus, lung pathology, acute lung injury, diffuse alveolar damage, acute fibrinous and organizing pneumonia, squamous metaplasia, pulmonary infarction, endothelial injury, invasive aspergillosis, cytomegalovirus coinfection, Epstein-Barr virus, herpes simplex virus
- MeSH terms
- Thyroid Nuclear Factor 1, CD68 Molecule, Adult, Aged, Aged, 80 and over, Aspergillosis, Aspergillus, Autopsy, Canada, Cytomegalovirus Infections, Cytomegalovirus, Female, Herpes Simplex, Humans, Immunohistochemistry, Keratins, Lung, Lung Diseases, Fungal, Male, Middle Aged, Nuclear Proteins, RNA, Viral, Transcription Factors, Viral Matrix Proteins, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Simplexvirus, Reverse Transcriptase Polymerase Chain Reaction, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review